Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-07-17 pm EDT			5-day change	1st Jan Change
8.16 ^CAD	-3.55%		+5.70%	+25.54%

Jun. 20	Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss	MT
Jun. 20	Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats	DJ

CanniMed Therapeutics Announces Continued Discussions with Aurora

January 23, 2018 at 12:00 am EST

CanniMed Therapeutics Inc. (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc. (TSX:ACB).

Latest news about Aurora Cannabis Inc.

Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss	Jun. 20	MT
Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats	Jun. 20	DJ
Transcript : Aurora Cannabis Inc., 2024 Earnings Call, Jun 20, 2024	Jun. 20
Aurora Cannabis Trims Q4 Net Loss	Jun. 20	MT
Aurora Cannabis Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	Jun. 20	CI
Aurora Cannabis Brief: Re-Affirming Target of Reaching Positive Free Cash Flow by December 31, 2024	Jun. 20	MT
Aurora Cannabis Brief: Says Q4 Represents Sixth Consecutive Quarter of Positive Adjusted EBITDA; Adds Ended Fiscal Year with a Cash Position of Near $180 Million with Cannabis Business Debt-Free	Jun. 20	MT
Aurora Cannabis Brief: Q4 Revenues $67.4 million Vs Forecast As Per Capital IQ of $69.54 Million and Last Year $64.03 Million	Jun. 20	MT
Aurora Cannabis Inc. Provides Consolidated Earnings Guidance for the First Quarter Ending June 30, 2024	Jun. 20	CI
Aurora Cannabis Introduces Resin Cartridges in Australia	Jun. 05	MT
Aurora Cannabis Brief: Unveiling Premium Resin Cartridges in Australia	Jun. 05	MT
US Government Reclassifies Marijuana to Less-Restrictive Category	May. 16	MT
Justice Department Set to Post Cannabis Reclassification Plans	May. 16	MT
Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors	May. 15	CI
Aurora Cannabis Inc. Marks First Shipment of Medical Cannabis to the New Zealand Market	May. 14	CI
Aurora Cannabis Brief: Up 0.3% In US Premarket As Marks First Shipment of Medical Cannabis to the New Zealand Market	May. 08	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	Apr. 30	DJ
TSX Down More Than 1% Today and More Than 2% For April, Having Hit Record Highs Earlier In the Month; But Cannabis Stocks Hit a High	Apr. 30	MT
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	Apr. 30	MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug	Apr. 30	MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug	Apr. 30	MT
DEA to Move to Reclassify Marijuana, Associated Press Reports	Apr. 30	MT
Aurora Cannabis Up 0.15% In US Premarket As Expands Offerings in Australia with New Range of Premium Dried Flower Products	Apr. 30	MT
Aurora Cannabis Brief: Expanding Offerings in Australia with New Range of Premium Dried Flower Products	Apr. 30	MT
Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products	Apr. 30	CI

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Aurora Cannabis Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

8.16 CAD

Average target price

8.779 CAD

Spread / Average Target

+7.58%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
AURORA CANNABIS INC.	+25.54%	325M
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.66B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.78B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.37B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B

Alternative Medicine

Aurora Cannabis Inc.

Equities

ACB

CA05156X8504

Pharmaceuticals

CanniMed Therapeutics Announces Continued Discussions with Aurora

Latest news about Aurora Cannabis Inc.

Chart Aurora Cannabis Inc.

Company Profile

Income Statement Evolution

Ratings for Aurora Cannabis Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Alternative Medicine